Genetic Obesity
4 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| EMANATE: A Study of Setmelanotide in Patients With Specific Gene Variants in the MC4R Pathway (NCT05093634) | Rhythm Pharmaceuticals, Inc. | 2021-12-10 |
| DAYBREAK: A Study of Setmelanotide in Participants With Specific Gene Variants in the Melanocortin-4 Receptor (MC4R) Pathway (NCT04963231) | Rhythm Pharmaceuticals, Inc. | 2021-11-30 |
| Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity (NCT03013543) | Rhythm Pharmaceuticals, Inc. | 2017-02-10 |
Track Genetic Obesity automatically
Every clearance here is in the API, with alerts when new ones post.